A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. [electronic resource]
Producer: 19990322Description: 1501-5 p. digitalISSN:- 1078-0432
- Adult
- Antibiotics, Antineoplastic -- administration & dosage
- Carcinoma, Squamous Cell -- drug therapy
- Combined Modality Therapy
- Cyclohexanes
- Dose-Response Relationship, Drug
- Female
- Humans
- Infusions, Intravenous
- Middle Aged
- Nausea -- chemically induced
- Neovascularization, Pathologic -- drug therapy
- Nervous System Diseases -- chemically induced
- O-(Chloroacetylcarbamoyl)fumagillol
- Salvage Therapy
- Sesquiterpenes -- administration & dosage
- Treatment Outcome
- Uterine Cervical Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.